Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Trading Statement

24 Feb 2016 07:00

RNS Number : 9368P
Microsaic Systems plc
24 February 2016
 

Microsaic Systems plc

 

("Microsaic", "Microsaic Systems" or the "Company") 

Update on Operations and Notice of Results

 

24 February 2016

 

Microsaic Systems plc (AIM: MSYS), the developer of miniaturised chip-based scientific instruments, announces an improved business performance in the six months to 31 December 2015. The Company sold seventeen 4000 MiD® units in H2 2015 versus six units in H1 2015. The Board anticipates that sales for H1 2016 will continue this positive trend. The Company is pleased to announce that it has also signed a new distributor agreement for the 4000 MiD®; details of which will be provided in the 2015 Annual Report.

 

The Company also announces that following a strategic review of the route-to-market for its advanced "triple quad" technology, the Company's development agreement announced on 25 September 2014 with an OEM partner has been terminated. The Company aims to finalise the development of its first triple quad prototype in the middle of 2016 and begin preliminary testing for defined applications. These actions will enable the Company to pursue a strategy of multiple outlets into each application area and hence reduce its dependency on any one international market participant.

 

Furthermore, the Company has identified a number of innovative new application areas for its current "single quad" products and early stage contacts are being made with appropriate companies to be partners for these. As a result, further OEM contracts are expected through 2016 and 2017. The Company has completed a review of its sales and marketing strategy, training and client literature - the results of which are in the process of being implemented.

 

The Company will announce its preliminary results for the year ended 31 December 2015 around 16 March 2016.

 

Enquiries:

 

Microsaic Systems plc

via Citigate Dewe Rogerson

Colin Nicholl, Chairman

 

Jim Ramage, CEO

 

 

 

Numis Securities Limited

+44 (0)20 7260 1000

Stuart Skinner (Nominated Adviser)

James Serjeant (Broker)

 

 

 

Citigate Dewe Rogerson (Financial PR)

+44 (0)20 7282 2948/1068

Mark Swallow, Marine Perrier

 

 

About Microsaic Systems

 

Microsaic Systems plc is a high technology company developing and marketing next generation mass spectrometry (MS) instruments for the analysis of gaseous, liquid and solid samples. Microsaic has successfully miniaturised mass spectrometry into a desktop instrument by integrating the key MS components onto patented chip technologies (called ionchip®, spraychip® and vac-chip™). Microsaic's MS products retain the functionality of larger, conventional MS systems but are substantially smaller, lighter, consume less energy and have lower running costs. The Microsaic 4000 MiD® is the world's smallest MS system.

 

Mass spectrometry is a 'gold-standard' analytical technique used across many industry sectors, including pharmaceutical, diagnostics and healthcare, government, energy, utilities, environmental, food and drink, security and defence, and industrial chemicals - a combined market estimated to grow to $2.5 billion by 2017. Microsaic aims to introduce compact, deployable MS products, based on its core technology, into a series of these target markets.

 

Microsaic Systems was established in 2001 by a team including founders from Imperial College London, and was admitted to AIM in April 2011 under the symbol MSYS. www.microsaic.com 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLFFIFFRIVFIR
Date   Source Headline
28th Oct 20149:16 amRNSHolding(s) in Company
14th Oct 20142:10 pmRNSHolding(s) in Company
10th Oct 20144:19 pmRNSHolding(s) in Company
10th Oct 20141:15 pmRNSExercise of Share Options
8th Oct 20147:00 amRNSDirectors' Dealings
7th Oct 20147:00 amRNSConditional Placing to Raise £4.4 million
30th Sep 20147:00 amRNSInterim Results
29th Sep 201412:23 pmRNSCommercial Agreement with Gilson Inc.
25th Sep 20147:00 amRNSMicrosaic Systems Signs Commercial Agreement
9th Sep 20147:00 amRNSPlexus chosen as commercial manufacturing partner
15th Jul 201410:06 amRNSDirectorate Change
23rd Jun 20143:08 pmRNSHolding(s) in Company
19th Jun 201412:02 pmRNSHolding(s) in Company
13th Jun 20149:00 amRNSDISTRIBUTION OF ANNUAL REPORT & ACCOUNTS
10th Jun 20149:10 amRNSExercise of share options
3rd Jun 20147:00 amRNSResult of AGM
30th May 20141:09 pmRNSNotification of Major Interest in Shares
6th May 201411:58 amRNSGRANT OF SHARE OPTIONS
30th Apr 20147:00 amRNSPreliminary Results
28th Apr 201412:33 pmRNSNotification of Major Interest in Shares
23rd Apr 20148:18 amRNSNotification of Major Interest in Shares
17th Apr 20149:19 amRNSHolding(s) in Company
15th Apr 20149:17 amRNSAppointment of Finance Director
14th Apr 20149:42 amRNSRe Agreement
11th Dec 20133:56 pmRNSHolding(s) in Company
21st Oct 20137:00 amRNSFormation of new Scientific Advisory Group
27th Sep 20137:00 amRNSInterim Results
1st Jul 20137:00 amRNSAppointment of Chairman
24th Jun 20137:00 amRNSIssue of Equity
4th Jun 20135:08 pmRNSHolding(s) in Company
4th Jun 20137:00 amRNSMicrosaic welcomes launch of the IsoleraT Dalton
31st May 201310:28 amRNSHolding(s) in Company
28th May 20132:44 pmRNSHolding(s) in Company
24th May 201311:23 amRNSResults of General Meeting
15th May 201311:23 amRNSResults of Annual General Meeting
7th May 20134:35 pmRNSDistribution of Circular of General Meeting
3rd May 20136:25 pmRNSConditional Placing to Raise up to £4.28 million
22nd Apr 20137:00 amRNSDistribution of Annual Report and Accounts
15th Apr 20137:00 amRNSPreliminary Results
10th Apr 20137:00 amRNSSigning of commercial agreement
15th Mar 20131:05 pmRNSHolding(s) in Company
14th Mar 20139:00 amRNSLaunch New Chip-based Mass Spectrometry Instrument
12th Dec 20129:36 amRNSGrant of Share Options
19th Oct 20124:45 pmRNSDirector/PDMR Shareholding
15th Oct 20122:26 pmRNSDirector/PDMR Shareholding
24th Sep 20127:00 amRNSAppointment of new CEO
24th Sep 20127:00 amRNSInterim Results
4th Sep 201210:00 amRNSAgreement
4th Jul 20129:46 amRNSGrant of Share Options
25th Jun 201210:29 amRNSMicrosaic Wins R&D100 Award

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.